Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 24.43%3.73B | 29.84%996.46M | 7.36%896.1M | 44.68%1.01B | 18.76%834.66M | -21.19%3B | 0.95%767.48M | -15.80%834.63M | -35.65%695.21M | -27.92%702.81M |
Cost of revenue | 26.86%2.96B | 32.55%795.04M | 8.24%710.05M | 49.42%796.55M | 20.95%660.38M | -20.69%2.33B | 2.43%599.81M | -14.77%656.01M | -36.26%533.1M | -27.45%546M |
Gross profit | 15.92%771.08M | 20.13%201.42M | 4.16%186.05M | 29.12%209.32M | 11.15%174.28M | -22.90%665.21M | -4.00%167.67M | -19.37%178.62M | -33.58%162.11M | -29.52%156.81M |
Operating expense | -3.67%757.34M | -7.61%186.48M | -4.65%187.63M | -1.98%189.36M | -0.27%193.87M | 5.41%786.21M | 8.90%201.84M | 2.35%196.79M | 1.17%193.18M | 9.63%194.41M |
Operating profit | 111.35%13.73M | 143.72%14.94M | 91.33%-1.58M | 164.25%19.96M | 47.90%-19.59M | -203.54%-121.01M | -219.75%-34.17M | -162.11%-18.17M | -158.47%-31.06M | -183.24%-37.6M |
Net non-operating interest income (expenses) | -3.74%-499K | 9.04%-171K | -3.06%-101K | -70.31%-109K | 9.92%-118K | 89.35%-481K | 95.48%-188K | 13.27%-98K | -102.26%-64K | 95.73%-131K |
Non-operating interest income | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Non-operating interest expense | -0.71%418K | -29.69%90K | 3.06%101K | 15.96%109K | 16.83%118K | -9.07%421K | 19.63%128K | -13.27%98K | -21.67%94K | -17.89%101K |
Total other finance cost | 35.00%81K | ---- | ---- | ---- | ---- | -98.52%60K | ---- | ---- | ---- | -98.98%30K |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -331K | 0 | ||||||||
Less:Other special charges | --331K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -62.81%325K | 262.50%145K | 361.76%89K | -68.34%63K | -95.81%28K | 137.85%874K | -99.14%40K | -101.12%-34K | 105.01%199K | 111.11%669K |
Income before tax | 110.97%13.23M | 142.48%14.58M | 91.33%-1.59M | 164.38%19.91M | 46.89%-19.68M | -211.16%-120.61M | -192.38%-34.32M | -156.89%-18.3M | -159.49%-30.93M | -202.71%-37.06M |
Income tax | -48.69%5.8M | -88.47%143K | -49.68%623K | -20.68%3.57M | -66.15%1.46M | -74.12%11.3M | 136.51%1.24M | -89.55%1.24M | -79.51%4.5M | -67.38%4.32M |
Net income | 105.63%7.43M | 140.60%14.44M | 88.69%-2.21M | 146.14%16.35M | 48.90%-21.14M | -303.35%-131.91M | -326.26%-35.56M | -196.11%-19.54M | -217.94%-35.43M | -281.18%-41.38M |
Net income continuous operations | 105.63%7.43M | 140.60%14.44M | 88.69%-2.21M | 146.14%16.35M | 48.90%-21.14M | -303.35%-131.91M | -326.26%-35.56M | -196.11%-19.54M | -217.94%-35.43M | -281.16%-41.38M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 105.63%7.43M | 140.60%14.44M | 88.69%-2.21M | 146.14%16.35M | 48.90%-21.14M | -303.35%-131.91M | -326.26%-35.56M | -196.11%-19.54M | -217.94%-35.43M | -281.18%-41.38M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 105.63%7.43M | 140.60%14.44M | 88.69%-2.21M | 146.14%16.35M | 48.90%-21.14M | -303.35%-131.91M | -326.26%-35.56M | -196.11%-19.54M | -217.94%-35.43M | -281.18%-41.38M |
Gross dividend payment | ||||||||||
Basic earnings per share | 105.76%2.33 | 140.85%4.53 | 88.63%-0.69 | 147.37%5.14 | 46.67%-6.65 | -299.31%-40.48 | -345.04%-11.09 | -200.53%-6.07 | -216.67%-10.85 | -253.19%-12.47 |
Diluted earnings per share | 105.58%2.26 | 140.39%4.5014 | 88.63%-0.6915 | 147.01%5.1148 | 46.67%-6.65 | -313.50%-40.48 | -323.77%-11.1453 | -207.49%-6.0841 | -226.21%-10.8795 | -270.59%-12.47 |
Dividend per share | 0.00%4 | 0.00%4 | 0 | 0 | 0 | -20.00%4 | -20.00%4 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |